The key player is represented by vascular smooth muscle cells, which are very sensitive to osteogenic molecules such as bone morphogenetic protein-2, osteopontin, and matrix γ-carboxyglutamic acid protein, Fetuin-A, or Klotho, which are upregulated in the setting of CKD. The gene discussed is BMP2; the disease is chronic kidney disease.